Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Invested Capital (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Invested Capital for 4 consecutive years, with 0.37% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 14.0% to 0.37% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.37% through Dec 2025, up 14.0% year-over-year, with the annual reading at 0.55% for FY2025, 15.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.37% at bioAffinity Technologies, up from 0.94% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.24% in Q4 2022, with the low at 26.65% in Q2 2025.
  • Average Return on Invested Capital over 4 years is 2.9%, with a median of 0.92% recorded in 2025.
  • Peak annual rise in Return on Invested Capital hit 102bps in 2025, while the deepest fall reached -2504bps in 2025.
  • Over 4 years, Return on Invested Capital stood at 0.24% in 2022, then plummeted by -363bps to 1.12% in 2023, then soared by 55bps to 0.51% in 2024, then grew by 27bps to 0.37% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.37%, 0.94%, and 26.65% for Q4 2025, Q3 2025, and Q2 2025 respectively.